APP and Alzheimer disease: Furthermore, studies have shown that activation of the Keap1/Nrf2/HO-1 pathway in the APP/PS1 transgenic AD mouse could lessen oxidative damage and enhance cognitive function, demonstrating its crucial role in the onset of AD [24].